| Literature DB >> 30370399 |
Tomoko Fujimoto1, Mitsuyoshi Hirokawa2, Ayana Suzuki1, Hisashi Ota1, Maki Oshita1, Takumi Kudo3, Mitsuhiro Fukushima4, Kaoru Kobayashi4, Akira Miyauchi4.
Abstract
PURPOSE: The goal of this study was to estimate the risk of malignant thyroid nodules being interpreted as benign based on ultrasound findings and to clarify the pathological features of these malignant nodules.Entities:
Keywords: interobserver variation; risk of malignancy; sonography; thyroid
Year: 2018 PMID: 30370399 PMCID: PMC6202066 DOI: 10.1055/a-0732-5795
Source DB: PubMed Journal: Ultrasound Int Open ISSN: 2199-7152
Table 1 Ultrasonographic classification (USC) for thyroid nodules in Kuma Hospital and ATA guidelines.
| Kuma Hospital | ATA guidelines | ||
|---|---|---|---|
| USC* | Description | Interpretation | Sonographic pattern |
| 1 | Round or oval anechoic lesion | Benign | Benign |
| 2 | Regular-shaped nodule with cystic change. The echo level of the solid lesion is similar to that of normal thyroid | Benign | Very low suspicion |
| 2.5 | Nodule with cystic change, partially irregular shape and/or strong echoes internally or at the capsule | Benign | Low suspicion |
| 3 | Solid and regular-shaped nodule. Internal echo is homogeneous or may have strong echoes internally or at the capsule | Borderline | Intermediate suspicion |
| 3.5 | Solid nodule with focally irregular shape | Malignant | High suspicion |
| 4 | Solid and irregular-shaped nodule. Internal echo is usually low and may have fine strong echoes internally | Malignant | High suspicion |
| 4.5 | Solid and irregular-shaped nodule with minor extrathyroidal extension | Malignant | High suspicion |
| 5 | Solid and irregular-shaped nodule with extrathyroidal extension | Malignant | High suspicion |
*Markedly calcified nodules are not evaluated.
Table 2 Re-evaluated ultrasound findings for 162 malignant thyroid nodules that were interpreted as benign based on ultrasound findings.
| Total N=162 | Low echogenicity N=59 (36.4%) | Irregular margins N=103 (63.6%) | Punctate microcalcification N=29 (17.9%) | T/W ≥1 N=33 (20.4%) | Invasiveness ## N = 0 | |
|---|---|---|---|---|---|---|
|
| ||||||
| <10 mm | 35 | 18 (51.4%) | 23 (65.7%) | 4 (11.4%) | 11 (31.4%) | 0 |
| 10–20 mm | 75 | 29 (38.7%) | 51 (68.0%) | 14 (18.7%) | 19 (25.3%) | 0 |
| 20–40 mm | 32 | 6 (18.8%) | 19 (59.4%) | 6 (18.8%) | 2 (6.3%) | 0 |
| ≥40 mm | 20 | 6 (30.0%) | 10 (50.0%) | 5 (25.0%) | 1 (5.0%) | 0 |
|
| ||||||
|
| 146 (90.1%) | 51 (34.9%) | 94 (64.4%) | 27 (18.5%) | 31 (21.2%) | 0 |
| Classic | 106 (72.6%) | 46 | 82 | 20 | 24 | 0 |
| Encapsulated V # | 25 (17.1%) | 2 | 14 | 7 | 4 | 0 |
| Follicular V # | 11 (7.5%) | 1 | 6 | 1 | 1 | 0 |
| Macrofollicular V # | 7 (4.8%) | 0 | 5 | 0 | 1 | 0 |
| Cribriform V | 3 (2.1%) | 2 | 0 | 0 | 1 | 0 |
| Tall cell V | 1 (0.7%) | 0 | 0 | 0 | 1 | 0 |
| Oxyphilic cell V | 1 (0.7%) | 0 | 0 | 0 | 0 | 0 |
|
| 12 (7.4%) | 6 (50.0%) | 7 (58.3%) | 1 (8.3%) | 2 (16.7%) | 0 |
| Minimally invasive | 7 (58.3%) | 4 | 3 | 1 | 1 | 0 |
| Widely invasive | 5 (41.7%) | 2 | 4 | 0 | 1 | 0 |
|
| 1 (0.6%) | 0 | 1 (100%) | 0 | 0 | 0 |
|
| 2 (1.2%) | 2 (100%) | 1 (50.0%) | 1 (50.0%) | 0 | 0 |
|
| 1 (0.6%) | 0 | 0 | 0 | 0 | 0 |
# : overlapping, V: variant, ## : rim calcifications with a small extrusive soft tissue component and extrathyroidal extension
T/W: taller-than-wide shape, PTC: papillary thyroid carcinoma, FTC: follicular thyroid carcinoma, PDTC: poorly differentiated thyroid carcinoma, MTC: medullary thyroid carcinoma, WDC-NOS: well differentiated carcinoma-not otherwise specified.
Fig. 1Ultrasound findings for malignant thyroid nodules that were originally interpreted as benign based on ultrasound findings. a Solid isoechoic nodule. b Solid hypoechoic nodule. c Cystic nodule. d Irregular margin. e Punctate microcalcifications. f Taller-than-wide shape ( a-e : B-mode, longitudinal view, f : B-mode, transverse view).
Fig. 2Papillary carcinoma, encapsulated variant. The mixed solid and cystic nodule was round and well-defined, with no punctate microcalcification (B-mode, longitudinal view).
Fig. 3Papillary carcinoma, encapsulated and follicular variant. The isoechoic solid nodule (arrow) is surrounded by a low echoic rim (B-mode, longitudinal view).
Fig. 4Papillary carcinoma, encapsulated and macrofollicular variant. The isoechoic solid nodule contains a focal cystic lesion without invasiveness or punctate microcalcification (B-mode, longitudinal view).
Table 3 Re-evaluated ultrasound patterns for 162 malignant thyroid nodules that were interpreted as benign based on ultrasound findings.
| Total N=162 | High N=119 (73.5%) | Intermediate N=15 (9.3%) | Low N=16 (9.9%) | Very low N=12 (7.4%) | |
|---|---|---|---|---|---|
|
| |||||
| <10 mm | 35 | 26 (74.3%) | 6 (17.1%) | 2 (5.7%) | 1 (2.9%) |
| 10–20 mm | 75 | 60 (80.0%) | 5 (6.7%) | 8 (10.7%) | 2 (2.7%) |
| 20–40 mm | 32 | 21 (65.6%) | 2 (6.3%) | 3 (9.4%) | 6 (18.8%) |
| ≥40 mm | 20 | 12 (60.0%) | 2 (10.0%) | 3 (15.0%) | 3 (15.0%) |
|
| |||||
| ND/UNS | 1 | 0 | 0 | 1 (100%) | 0 |
| Benign | 14 | 8 (57.1%) | 0 | 4 (28.6%) | 2 (14.3%) |
| AUS | 13 | 8 (61.5%) | 2 (15.4%) | 1 (7.7%) | 2 (15.4%) |
| Follicular neoplasm | 6 | 4 (66.7%) | 1 (16.7%) | 0 | 1 (16.7%) |
| Suspected malignancy | 22 | 16 (72.7%) | 0 | 4 (18.2%) | 2 |
| Malignant | 106 | 83 (78.3%) | 12 (11.3%) | 6 (5.7%) | 5 (4.7%) |
|
| |||||
|
| 146 (90.1%) | 108 (74.0%) | 13 (8.9%) | 15 (10.3%) | 10 (6.9%) |
| Classic | 106 | 82 | 9 | 8 | 7 |
| Encapsulated V # | 25 | 18 | 1 | 3 | 3 |
| Follicular V # | 11 | 7 | 1 | 3 | 0 |
| Macrofollicular V # | 7 | 5 | 0 | 1 | 1 |
| Cribriform V | 3 | 1 | 2 | 0 | 0 |
| Tall cell V | 1 | 1 | 0 | 0 | 0 |
| Oxyphilic cell V | 1 | 0 | 0 | 1 | 0 |
|
| 12 (7.4%) | 8 (66.7%) | 2 (16.7%) | 1 (8.3%) | 1 (8.3%) |
| Minimally invasive | 7 | 4 | 2 | 1 | 0 |
| Widely invasive | 5 | 4 | 0 | 0 | 1 |
|
| 1 (0.6%) | 1 (100%) | 0 | 0 | 0 |
|
| 2 (1.2%) | 2 (100%) | 0 | 0 | 0 |
|
| 1 (0.6%) | 0 | 0 | 0 | 1 (100%) |
# : overlapping, ND/UNS: nondiagnostic or unsatisfactory, AUS: atypia of undetermined significance, V: variant, PTC: papillary thyroid carcinoma, FTC: follicular thyroid carcinoma, PDTC: poorly differentiated thyroid carcinoma, MTC: medullary thyroid carcinoma, WDC-NOS: well differentiated carcinoma-not otherwise specified.
Fig. 5Widely invasive follicular thyroid carcinoma. Satellite nodules (red, yellow, and white arrows) were interpreted as a benign nodular goiter ( a B-mode, longitudinal view, b cut surface).